|
1
|
Novik AV, Protsenko SA, Baldueva IA,
Ivantsov AO, Nekhaeva TL, Akhaeva ZY, Yanus GA, Iyevleva AG and
Imyanitov EN: Vemurafenib-induced progression of breast cancer: A
case report and review of the literature. Target Oncol. 11:235–238.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Araki K and Ito Y: A review multigene
assays for Clinical Utility in breast cancer. Gan to kagaku ryoho.
Gan To Kagaku Ryoho. 43:1332–1340. 2016.(In Japanese).
|
|
3
|
Plourde N, Brown HK, Vigod S and Cobigo V:
Contextual factors associated with uptake of breast and cervical
cancer screening: A systematic review of the literature. Women
Health. 56:906–925. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Post KE and Flanagan J: Web based
survivorship interventions for women with breast cancer: An
integrative review. Eur J Oncol Nurs. 25:90–99. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thivya KS, Sakthivel P and Venkata Sai PM:
Analysis of framelets for breast cancer diagnosis. Technol Health
Care. 24:21–29. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Korkmaz SA, Korkmaz MF and Poyraz M:
Diagnosis of breast cancer in light microscopic and mammographic
images textures using relative entropy via kernel estimation. Med
Biol Eng Comput. 54:561–573. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zuo X, Chen L, Liu L, Zhang Z, Zhang X, Yu
Q, Feng L, Zhao X and Qin T: Identification of a panel of complex
autoantigens (LGALS3, PHB2, MUC1, and GK2) in combination with
CA15-3 for the diagnosis of early-stage breast cancer. Tumour Biol.
37:1309–1317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang DY, Done SJ, McCready DR, Boerner S,
Kulkarni S and Leong WL: A new gene expression signature, the
ClinicoMolecular Triad Classification, may improve prediction and
prognostication of breast cancer at the time of diagnosis. Breast
Cancer Res. 13:R922011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miki Y: Gene expression-based diagnosis of
efficacy of chemotherapy for breast cancer. Breast Cancer.
17:97–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Richman I, Asch SM, Bendavid E,
Bhattacharya J and Owens DK: Breast density notification
legislation and breast cancer stage at diagnosis: Early evidence
from the SEER registry. J Gen Intern Med. 32:603–609. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abdoli G, Bottai M, Sandelin K and Moradi
T: Breast cancer diagnosis and mortality by tumor stage and
migration background in a nationwide cohort study in Sweden.
Breast. 31:57–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang S, Zhou F, Sun Y, Wei L, Zhu S, Yang
R, Huang Y and Yang J: CEA in breast ductal secretions as a
promising biomarker for the diagnosis of breast cancer: A
systematic review and meta-analysis. Breast Cancer. 23:813–819.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kruger S, Mottaghy FM, Buck AK, Maschke S,
Kley H, Frechen D, Wibmer T, Reske SN and Pauls S: Brain metastasis
in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for
diagnosis in the initial staging. Nuklearmedizin. 50:101–106.
2011.
|
|
14
|
Peng KQ, Huang ZL, Xie CM, Chen L, Ouyang
Y, Zheng QS, Zhang Y, He HQ and Wu PH: Application of dynamic
contrast enhancement MRI and post-processing technique for
diagnosis of breast cancer. Ai Zheng. 28:549–554. 2009.(In
Chinese). PubMed/NCBI
|
|
15
|
Youk JH, Son EJ, Kim EK, Kim JA, Kim MJ,
Kwak JY and Lee SM: Diagnosis of breast cancer at dynamic MRI in
patients with breast augmentation by paraffin or silicone
injection. Clin Radiol. 64:1175–1180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morrow M, Waters J and Morris E: MRI for
breast cancer screening, diagnosis, and treatment. Lancet.
378:1804–1811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu T, Cheng T, Xu W, Yan WL, Liu J and
Yang HL: A meta-analysis of 18FDG-PET, MRI and bone scintigraphy
for diagnosis of bone metastases in patients with breast cancer.
Skeletal Radiol. 40:523–531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawashima H, Inokuchi M, Furukawa H and
Kitamura S: Accuracy for a diagnosis of breast cancer spread using
3.0T MRI. Nihon rinsho. Nihon Rinsho. 70(Suppl 7): S5306–S5308.
2012.(In Japanese).
|
|
19
|
Kwong A, Chen J, Shin VY, Ho JC, Law FB,
Au CH, Chan TL, Ma ES and Ford JM: The importance of analysis of
long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of
familial breast cancer. Cancer Genet. 208:448–454. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Woodson AH, Muse KI, Lin H, Jackson M,
Mattair DN, Schover L, Woodard T, McKenzie L, Theriault RL,
Hortobágyi GN, et al: Breast cancer, BRCA mutations, and attitudes
regarding pregnancy and preimplantation genetic diagnosis.
Oncologist. 19:797–804. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Derks-Smeets IA, de Die-Smulders CE,
Mackens S, van Golde R, Paulussen AD, Dreesen J, Tournaye H,
Verdyck P, Tjan-Heijnen VC, Meijer-Hoogeveen M, et al: Hereditary
breast and ovarian cancer and reproduction: an observational study
on the suitability of preimplantation genetic diagnosis for both
asymptomatic carriers and breast cancer survivors. Breast Cancer
Res Treat. 145:673–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Heacock L, Melsaether AN, Heller SL, Gao
Y, Pysarenko KM, Babb JS, Kim SG and Moy L: Evaluation of a known
breast cancer using an abbreviated breast MRI protocol: Correlation
of imaging characteristics and pathology with lesion detection and
conspicuity. Eur J Radiol. 85:815–823. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ethier JL and Amir E: The Role of the
21-gene recurrence score in breast cancer treatment. Mol Diagn
Ther. 20:307–313. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoogland AM, Bottcher R, Verhoef E,
Jenster G and van Leenders GJ: Gene-expression analysis of gleason
grade 3 tumor glands embedded in low- and high-risk prostate
cancer. Oncotarget. 7:37846–37856. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Printz C: New AJCC cancer staging manual
reflects changes in cancer knowledge. Cancer. 116:2–3. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park HS, Park S, Kim JH, Lee JH, Choi SY,
Park BW and Lee KS: Clinicopathologic features and outcomes of
metaplastic breast carcinoma: Comparison with invasive ductal
carcinoma of the breast. Yonsei Med J. 51:864–869. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cho JH, Park JM, Park HS, Park S, Kim SI
and Park BW: Oncologic safety of breast-conserving surgery compared
to mastectomy in patients receiving neoadjuvant chemotherapy for
locally advanced breast cancer. J Surg Oncol. 108:531–536. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Telegrafo M, Rella L, Stabile Ianora AA,
Angelelli G and Moschetta M: Breast MRI background parenchymal
enhancement (BPE) correlates with the risk of breast cancer. Magn
Reson Imaging. 34:173–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Masood S, El-Gabry E, Zhang C and Wang Z:
The potential of identification of a malignancy-associated
biomarker in breast cancer diagnosis and research: hTERT gene DNA
methylation. Diagn Cytopathol. 44:670–675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoon H, Yoon D, Yun M, Choi JS, Park VY,
Kim EK, Jeong J, Koo JS, Yoon JH, Moon HJ, et al: Metabolomics of
Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic
Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission
Tomography-Computed Tomography, Dynamic Contrast-Enhanced and
Diffusion-Weighted Imaging MRI. PLoS One. 11:e01599492016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu S, Berg WA, Zuley ML, Kurland BF,
Jankowitz RC, Nishikawa R, Gur D and Sumkin JH: Breast MRI contrast
enhancement kinetics of normal parenchyma correlate with presence
of breast cancer. Breast Cancer Res. 18:762016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chung MT, Lourenco AP and Mainiero MB:
Screening Breast MRI in Women with a Personal History of Breast
Cancer. Breast J. 22:252–253. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mannan AU, Singh J, Lakshmikeshava R,
Thota N, Singh S, Sowmya TS, Mishra A, Sinha A, Deshwal S, Soni MR,
et al: Detection of high frequency of mutations in a breast and/or
ovarian cancer cohort: Implications of embracing a multi-gene panel
in molecular diagnosis in India. J Hum Genet. 61:515–522. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Soliman NA and Yussif SM: Ki-67 as a
prognostic marker according to breast cancer molecular subtype.
Cancer Biol Med. 13:496–504. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Khaled WT, Choon Lee S, Stingl J, Chen X,
RazaAli H, Rueda OM, Hadi F, Wang J, Yu Y, Chin SF, et al: BCL11A
is a triple-negative breast cancer gene with critical functions in
stem and progenitor cells. Nat Commun. 6:59872015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu YL, Yao R, Li J, Zhou YD, Mao F, Pan B
and Sun Q: FOXC1 overexpression is a marker of poor response to
anthracycline-based adjuvant chemotherapy in sporadic
triple-negative breast cancer. Cancer Chemother Pharmacol.
79:1205–1213. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhong ZB, Shan M, Qian C, Liu T, Shi QY,
Wang J, Liu Y, Liu Y, Huang YX and Pang D: Prognostic significance
of HOXD13 expression in human breast cancer. Int J Clin Exp Pathol.
8:11407–11413. 2015.PubMed/NCBI
|
|
39
|
Mendoza G, Portillo A and Olmos-Soto J:
Accurate breast cancer diagnosis through real-time PCR her-2 gene
quantification using immunohistochemically-identified biopsies.
Oncol Lett. 5:295–298. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Swayampakula AK, Dillis C and Abraham J:
Role of MRI in screening, diagnosis and management of breast
cancer. Expert Rev Anticancer Ther. 8:811–817. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tozaki M: Diagnosis of breast cancer: MDCT
versus MRI. Breast Cancer. 15:205–211. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schwentner L, Wolters R, Wischnewsky M,
Kreienberg R and Wockel A: Survival of patients with bilateral
versus unilateral breast cancer and impact of guideline adherent
adjuvant treatment: A multi-centre cohort study of 5292 patients.
Breast. 21:171–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
